10x Genomics Inc (TXG)

10x Genomics (TXG) Stock Price & Analysis


TXG Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$23.81 - $100.00
Previous Close$48.65
Average Volume (3M)1.35M
Market CapN/A
Enterprise ValueN/A
Total Cash (Recent Filing)$452.39M
Total Debt (Recent Filing)$96.23M
Price to Earnings (P/E)-33.0
Next EarningsFeb 15, 2023
Next Dividend Ex-DateN/A
Dividend YieldN/A
EPS (TTM)-1.48
Shares Outstanding114,463,521
Standard Deviation0.16
10 Day Avg. Volume1,423,037
30 Day Avg. Volume1,349,896
Price to Book (P/B)6.89
Price to Sales (P/S)12.56
Price to Cash Flow (P/CF)199.90
P/FCF Ratio-36.60
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Price Target Upside12.64% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering5



Risk Analysis

Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products

Product Monthly Users

Sorry, No Data Available
There is no website visitor data available for this stock.



What was 10x Genomics’s price range in the past 12 months?
10x Genomics lowest stock price was $23.81 and its highest was $100.00 in the past 12 months.
    What is 10x Genomics’s market cap?
    Currently, no data Available
    When is 10x Genomics’s upcoming earnings report date?
    10x Genomics’s upcoming earnings report date is Feb 15, 2023 which is in 18 days.
      How were 10x Genomics’s earnings last quarter?
      10x Genomics released its earnings results on Nov 02, 2022. The company reported -$0.37 earnings per share for the quarter, beating the consensus estimate of -$0.467 by $0.097.
        Is 10x Genomics overvalued?
        According to Wall Street analysts 10x Genomics’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does 10x Genomics pay dividends?
          10x Genomics does not currently pay dividends.
          What is 10x Genomics’s EPS estimate?
          10x Genomics’s EPS estimate is -$0.29.
            How many shares outstanding does 10x Genomics have?
            10x Genomics has 95,596,270 shares outstanding.
              What happened to 10x Genomics’s price movement after its last earnings report?
              10x Genomics reported an EPS of -$0.37 in its last earnings report, beating expectations of -$0.467. Following the earnings report the stock price went up 18.499%.
                Which hedge fund is a major shareholder of 10x Genomics?
                Among the largest hedge funds holding 10x Genomics’s share is ARK Investment Management LLC. It holds 10x Genomics’s shares valued at 130M.


                  10x Genomics Stock Smart Score

                  The 10x Genomics stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                  Learn more about TipRanks Smart Score

                  Company Description

                  10x Genomics Inc

                  10X Genomics, Inc. is a life science technology company, which engages in building products to interrogate, understand and master biology. Its integrated solutions include single cell transcriptomics, single cell genomics, single cell epigenomes, linked-reads genomics and spatial transcriptomics. The company's products include Single Cell Gene Expression, Immune Profiling, CNV, ATAC, and Genome and Exome. 10X Genomics was founded by Serge Saxonov, Ben Hindson, Kevin D. Ness and Eduard Diviu Terradas on July 2, 2012 and is headquartered in Pleasanton, CA.


                  Forecast EPS vs Actual EPS

                  Similar Stocks
                  Price & Change
                  Medpace Holdings

                  Popular Stocks

                  What's Included in PREMIUM?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis